The Journal of Neuroscience, July 2, 2003, 23(13):5789-5798
Previous Article | Next Article 
High Threshold for Induction of the Stress Response in Motor Neurons Is Associated with Failure to Activate HSF1
Zarah Batulan,1
Gayle A. Shinder,1
Sandra Minotti,1
Bei Ping He,2
Mohammad M. Doroudchi,1
Josephine Nalbantoglu,1
Michael J. Strong,2,3 and
Heather D. Durham1
1Montreal Neurological Institute and Department
of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada H3A
2B4, 2Neurodegeneration Research Group, The John P.
Robarts Research Institute, and 3Department of
Clinical Neurological Sciences, The University of Western Ontario, London,
Ontario, Canada N6A 5A5
 |
Abstract
|
|---|
Heat shock protein 70 (Hsp70) protects cultured motor neurons from the
toxic effects of mutations in Cu/Zn-superoxide dismutase (SOD-1),
which is responsible for a familial form of the disease, amyotrophic lateral
sclerosis (ALS). Here, the endogenous heat shock response of motor neurons was
investigated to determine whether a high threshold for activating this
protective mechanism contributes to their vulnerability to stresses associated
with ALS. When heat shocked, cultured motor neurons failed to express Hsp70 or
transactivate a green fluorescent protein reporter gene driven by the Hsp70
promoter, although Hsp70 was induced in glial cells. No increase in Hsp70
occurred in motor neurons after exposure to excitotoxic glutamate or
expression of mutant SOD-1 with a glycine
alanine substitution at
residue 93 (G93A), nor was Hsp70 increased in spinal cords of G93A SOD-1
transgenic mice or sporadic or familial ALS patients. In contrast, strong
Hsp70 induction occurred in motor neurons with expression of a constitutively
active form of heat shock transcription factor (HSF)-1 or when proteasome
activity was sufficiently inhibited to induce accumulation of an alternative
transcription factor HSF2. These results indicate that the high threshold for
induction of the stress response in motor neurons stems from an impaired
ability to activate the main heat shockstress sensor, HSF1.
Key words: ALS; amyotrophic lateral sclerosis; heat shock; HSF1; HSF2; Hsp70; motor neuron; proteasome inhibition
 |
Introduction
|
|---|
The heat shock response is an evolutionarily conserved, cytoprotective
mechanism mediated by stress-induced transcription of genes encoding heat
shockstress proteins (HSP) (for review, see
Morimoto et al., 1997
).
Families of stress-induced HSPs and constitutively expressed heat shock
cognate proteins (HSC) facilitate nascent protein folding, refolding, or
degradation of abnormally folded proteins, protein targeting, and cellular
signaling (Gabai et al., 1997
;
Morimoto and Santoro, 1998
;
Meriin et al., 1999
).
Eukaryotic expression of HSPs is mediated by binding and activation of heat
shock transcription factors (HSFs) to heat shock elements (HSEs) on
HSP promoters (Morimoto and
Santoro, 1998
). Environmental and physiological stresses activate
transcription of HSP genes in mammals primarily through HSF1
(Morimoto, 1998
), whereas HSF2
participates in heat shock gene transactivation developmentally
(Min et al., 2000
) and in the
presence of proteasomal inhibitors (Mathew
et al., 1998
).
HSPs can protect neural cells from various stresses including hyperthermia,
ischemia, oxidative stress, and excitotoxicity
(Lowenstein et al., 1991
;
Rordorf et al., 1991
;
Uney et al., 1993
;
Yenari et al., 1998
). Findings
from our laboratory extended the neuroprotective role of the major
stress-inducible heat shock protein 70 isoform (Hsp70) to a culture model of
amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized
by loss of motor neurons in the brain and spinal cord. Approximately 20% of
familial ALS (FALS) cases are caused by autosomal dominant mutations in
Cu/Zn-superoxide dismutase (SOD-1)
(Rosen et al., 1993
).
Toxicity of mutant SOD-1 is attributable to a gain of function rather than
a loss of the primary enzymatic function, dismutation of superoxide to
hydrogen peroxide. One proposed mechanism of disease pathogenesis is that
mutations in SOD-1 confer structural changes in the protein, resulting in
altered solubility and aggregation (Deng
et al., 1993
; Bruijn et al.,
1997
; Durham et al.,
1997
; Johnston et al.,
2000
; Shinder et al.,
2001
). Consistent with the cellular response to accumulation and
aggregation of abnormal proteins, cell lines surviving stable overexpression
of mutant SOD-1 exhibit upregulation of the HSPs, Hsp70, Hsp25, and
B-crystallin and an increase in chaperoning activity. Expression of
mutant SOD-1 in motor neurons of dissociated murine spinal cord cultures
resulted in aggregation of this protein into inclusions and loss of viability
(Durham et al., 1997
). Both
manifestations of mutant SOD-1 toxicity were delayed by gene transfer of Hsp70
(Bruening et al., 1999
),
suggesting that an insufficient stress response in motor neurons increases
their vulnerability to toxicity. The present study investigated the endogenous
heat shock response in motor neurons, as monitored by induction of Hsp70 and
other HSPs after exposure to hyperthermia and two stresses associated with
ALS: glutamate excitotoxicity and expression of SOD-1 with glycine
alanine substitution at residue 93 (G93A SOD-1). The data show a high
threshold for induction of the stress response in motor neurons attributable
to the lack of activation of the major stress-sensing transcription factor
HSF1.
 |
Materials and Methods
|
|---|
Spinal cord cultures. Primary cultures of dissociated spinal cord
and dorsal root ganglia (DRG) were prepared from embryonic day 13 CD1 mice and
cultured on poly-D-lysine-coated glass coverslips as described
previously (Roy et al., 1998
).
Cultures were used 48 weeks after plating and large motor neurons were
distinguished from other cell types as described previously
(Roy et al., 1998
).
Transgenic mice. The following lines were maintained in our animal
facilities: B6SJL-TgN(SOD1G93A)1Gur (expressing G93A mutant human
SOD-1; hemizygotes become paralyzed in one or more limbs at
4 months of
age), B6.Cg-TgN(SOD1G93A) dl1Gur (hemizygotes develop
clinical disease at
8 months), and B6.Cg-TgN(SOD1)2Gur [expressing
wild-type (wt) human SOD-1] (Dal Canto and Gurney,
1994
,
1995
;
Chiu et al., 1995
).
Nontransgenic littermates were used as controls. Genotyping was performed by
PCR analysis of DNA isolated from ear tissue according to protocols provided
by the Jackson Laboratory (Bar Harbor, ME). End-stage disease was defined as
paralysis in one or both hind limbs. To obtain spinal cords, mice were killed
by intraperitoneal injection of ketaminexylazine (Ketaset,
WyethAyerst, Montreal, Quebec, Canada; Rompun, Chemagro Limited,
Etobicoke, Ontario, Canada). All procedures were within the guidelines of the
Canadian Council of Animal Care and the Animal Care Committee of McGill
University.
Human spinal cord sections. Archival paraffin-embedded cervical
spinal cord sections were studied from control (two cases; neurologically
normal), sporadic ALS (three cases), and autosomal dominant FALS (three cases,
one SOD-1 A4V mutation and two without linkage to SOD-1).
Exposure of spinal cord DRG cultures to thermal and excitotoxic
stress. For heat shock, spinal cord cultures were placed in minimum
essential medium enriched with 5 gm of glucose without sodium bicarbonate, pH
7.2, heat shocked in a temperature controlled water bath, and recovered for
variable periods at 37°C5% CO2 before analysis of HSP
expression. To induce excitotoxic stress, an appropriate volume of a 100
mM stock of glutamic acid (Sigma, Oakville, ON) was added.
Microinjection of plasmid vectors into cultured motor neurons. To
study the effect of G93A mutant and wild-type human SOD-1 on Hsp70 induction
in motor neurons, cDNAs were subcloned into pCEP4 and microinjected into motor
neuron nuclei at 200 µg/ml in Tris-EDTA as described previously
(Durham et al., 1997
).
pcDNA3.1 plasmids encoding the following forms of human HSF1 were provided
courtesy of Dr. R. Voellmy (University of Miami, Miami, FL) and injected at
0.5 µg/ml; HSF1 wt, constitutively activated HSF1 (HSF1
(+) or BH-S; resulting from deletion of amino acids 202316,
which regulates transactivational competence of HSF1), and nonactivatable HSF1
(HSF1 (-) or AV-ST; resulting from deletion of amino acids
453523, which spans the transcriptional activation domain)
(Zuo et al., 1995
). Plasmid
containing the green fluorescent protein (GFP) gene under the control of the
inducible human Hsp70 promoter [pEGFP (enhanced GFP)-HSE-GFP; courtesy of Dr.
R. I. Morimoto, Northwestern University, Evanston, IL] was injected at 0.1
µg/ml, and 70 kDa dextran fluorescein or dextran tetramethylrhodamine (TMR)
(20 µg/µl; Molecular Probes, Eugene, OR) was included to mark injected
cells. After microinjection, coverslips were transferred to 5%
CO2-equilibrated culture medium supplemented with 0.75% gentamycin
and placed in a 37°C5% CO2 incubator. Cultures were
either immunolabeled with antibody to Hsp70 or imaged for GFP expression in
real time using MetaVue (GFP exposure time, 2 sec; TMR exposure time, 0.625
sec; Universal Imaging Corporation, Downington, PA).
Treatment with proteasomal inhibitors. Spinal cord cultures were
transferred to CO2-equilibrated medium containing either MG132 (at
final concentrations of 0.1, 1, 2.5, or 5 µM; Peptide Institute,
Minoh, Japan) or DMSO carrier and were incubated overnight.
Antibodies. Primary antibodies were used against the following:
SOD-1 (clone SDG6, 1:300, Sigma; SOD-100, 1:100, Stressgen
Biotechnologies, Victoria, BC), Hsp70 (SPA-810 for inducible Hsp70, 1:1000 for
blots, 1:100 for immunolabeling of cultures and mouse tissue sections, 1:500
for human tissue sections, Stressgen Biotechnologies; W27 for both inducible
and constitutive Hsp70, 1:100 Santa Cruz Biotechnology, Santa Cruz, CA), Hsc70
(K19, 1:1000 for blots; Santa Cruz Biotechnology), Hsp25 (SPA-801 for rodent
Hsp25 with no cross reaction to Hsp27 primate isoform, 1:500/1000 for blots;
Stressgen Biotechnologies), Hsp27 (M20, recognizes primate Hsp27 and rodent
Hsp25, 1:100 for immunolabeling of cultures, 1:1000 for sections; Santa Cruz
Biotechnology),
B-crystallin (SPA-222 and SPA-223, 1:1000 for blots,
1:100 for immunolabeling; Stressgen Biotechnologies), ubiquitin (1:1000; Dako,
Carpinteria, CA), HSF1 (SPA-950, 1:100; Stressgen Biotechnologies), HSF2
(1:10; courtesy of Dr. R. I. Morimoto, Northwestern University, Evanston, IL),
actin (clone C4, 1:1000; ICN Biomedicals, Cleveland, OH), glial fibrillary
acidic protein (GFAP) (Z0334, 1:100 for immunolabeling of cultures, 1:2000 for
sections; Dako), neurofilament heavy chain (N-4142, 1:100; Sigma),
nitrotyrosine (1:100; Upstate Biotechnology, Lake Placid, NY), MAC-1 (courtesy
of Dr. Sam David, McGill University, Montreal, Canada). For epifluorescence
microscopy, cultures were labeled with appropriate secondary antibodies
(Alexa-fluor 1:100; Molecular Probes). For Vectastain ABC detection systems,
biotin-conjugated secondary antibodies were used (1:100; Vector Laboratories,
Burlin-game, CA). For blots, secondary antibodies conjugated to horseradish
peroxidase (HRP) were used (mouse IgG and rat IgG, 1:3000, Jackson
ImmunoResearch, West Grove, PA; rabbit IgG and goat IgG, 1:50001:10000,
Dako).
Sample preparation for Western blotting. Spinal cord cultures were
harvested in lysis buffer containing the following: 20 mM HEPES, pH
7.5, 100 mM KCl, 5% glycerol, 0.1% Nonidet P-40, 0.1 mM
phenylmethylsulfonyl fluoride (PMSF). After 30 min of incubation on ice, cell
lysates were centrifuged at 12,700 x g for 15 min at 4°C.
Lumbar spinal cords from mice were homogenized in 500 µl of the following
lysis buffer: PBS, pH 8.0, containing 0.5% Nonidet-P40, 0.2% digitonin, and
0.23 mM PMSF. Cellular debris was pelleted by centrifugation at
15,400 x g for 15 min at 4°C. Supernatant fractions of
culture or spinal cord homogenates were collected and protein concentrations
were determined using the DC Protein Assay (Bio-Rad, Mississauga, Canada).
Western blotting. For spinal cord culture samples, 10 µg of
protein were mixed with an equal volume of sample buffer (130 mM
Tris, pH 6.8, 20% glycerol, 2% SDS, 10%
-mercaptoethanol, 0.08%
bromophenol blue), boiled for 2 min, electrophoresed on 10%
SDSpolyacrylamide gels, and transferred to Bio-Rad trans-blot
transfer medium. Membranes were blocked for 1 hr with 5% milk in TBST (50
mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20) and
then incubated for 2 hr at room temperature (RT) or overnight at 4°C with
primary antibody diluted in TBST containing 5% milk and 0.02% NaN3.
After washing in TBST, blots were incubated in HRP-conjugated secondary
antibody5% milkTBST for 2 hr at RT. Protein bands were
visualized on x-ray film after incubation of the blots in the Renaissance
Western blot chemiluminescence reagent (NEN, Boston, MA). Films were scanned
using Microtek (Torrance, CA) Scan Wizard. Expression of HSPs was normalized
to actin by quantitating band density on films using ImageQuant software
(Amersham Biosciences, Baie D'Urfe, Quebec, Canada).
For lumbar spinal cord homogenates, 10 µg of protein were mixed with an
equal volume of sample buffer, boiled for 5 min, electrophoresed on 12.5%
SDSpolyacrylamide gels, and transferred to nitrocellulose. Membranes
were blocked overnight at 4°C in TBST-milk. Incubations with primary and
secondary antibodies were 1 hr at RT. Protein bands were detected as described
for culture samples. Hsp25 and
B-crystallin levels were normalized to
tubulin by quantitating bands using NIH Image or ImageQuant software.
Immunocytochemistry. Immunocytochemistry using fluorescent
dye-conjugated secondary antibodies was performed as described previously
(Roy et al., 1998
).
Biotin-conjugated secondary antibodies were visualized using the Vectastain
ABC peroxidase kit (Vector Laboratories) and 0.05% DAB.
Immunohistochemistry. Lumbar spinal cords from transgenic mice
were placed in Histo-Prep frozen tissue-embedding media (Fisher Scientific,
Ottawa, Canada) and frozen in isopentane. Twenty micrometer cross sections
were mounted onto glass slides and fixed in 3% paraformaldehyde for 30 min,
permeabilized in 0.5% Nonidet-P40PBS for 5 min, fixed in 3%
paraformaldehyde for 2 min, and blocked for 3 hr at RT. To prevent nonspecific
labeling with mouse monoclonal primary antibodies, FAB fragment
anti-mouse IgG H+L (Jackson ImmunoResearch) was added for 30 min. Endogenous
peroxidase activity was quenched by 5 min incubation with 2%
H2O2. Primary antibodies were incubated overnight and
detected using biotinylated secondary antibodies (1 hr at RT), Vectastain ABC
peroxidase system, and 0.05% DAB. Sections were dehydrated in ethanol, dipped
in xylene, and mounted in Permount (Fisher Scientific).
Human ALS spinal cord sections were deparaffinized using routine
techniques. Antigen retrieval was performed at pH 10.0, and slides were
incubated with 3% H2O2 for 5 min, 5% BSA for 20 min, and
0.1% trypsin0.1 M PBS, pH 7.2, for 15 min at 37°C. Sections were
labeled with either SPA-810 monoclonal antibody recognizing Hsp70 (1:500) or a
goat antibody recognizing Hsp27 (M20; 1:1,000) overnight at 4°C and
detected using HRP-conjugated secondary antibodies and the Elite Vectastain
ABC peroxidase system (Vector Laboratories) with 0.05% DAB.
 |
Results
|
|---|
Heat shock-induced Hsp70 expression in glial cells but not motor
neurons
Because induction of Hsp70 is a well characterized feature of the cellular
response to hyperthermia, Hsp70 expression was used as the primary marker to
investigate the heat shockstress response in spinal cord cells. Primary
spinal cord cultures were exposed for 1 hr to increasing temperatures
(4042°C) and then incubated for 2 hr at 37°C to allow for
protein synthesis. Initially, HSP expression was examined by Western blotting
to screen for thermally induced changes
(Fig. 1). Inducible Hsp70 was
minimal to nondetectable in cultures maintained at the 37°C control
temperature, but increasing levels were observed in cultures exposed to
temperatures above 40°C. When normalized to levels of actin, an
approximate twofold increase in Hsp70 occurred at 42°C compared with
41°C. Expression of other HSPs, Hsp25, Hsc70, and
B-crystallin was
evaluated by immunoblotting, but no consistent increases were observed after
heat shock at 4042°C relative to levels at the control temperature
of 37°C.

View larger version (62K):
[in this window]
[in a new window]
|
Figure 1. Heat shock induces Hsp70 in spinal cord cultures. Spinal cord cultures were
subjected to increasing heat shock temperatures (4042°C) for 1 hr,
followed by 2 hr recovery at 37°C. Western blots were probed with
antibodies to HSPs [Hsp70 (SPA-810), Hsp25 (SPA-801), Hsc70 (K19),
and B-crystallin (SPA-222)] and actin as loading control. Blots shown
are representative of three different experiments. Only Hsp70 was
upregulated.
|
|
To determine the cell types in spinal cord cultures that upregulated Hsp70
after heat shock, immunocytochemistry was performed
(Fig. 2). After heat shock for
1 hr at 42°C and 2 hr of recovery at 37°C, numerous non-neuronal cells
expressed Hsp70, whereas motor neurons did not
(Fig. 2B). Double
labeling of cultures with antibodies to Hsp70 and the high molecular weight
neurofilament protein confirmed the lack of Hsp70 in large neurons with motor
neuron morphology as well as DRG and other neurons in the culture at this heat
shock condition (our unpublished data). Double labeling with antibody against
the astrocytic marker GFAP confirmed that astrocytes expressed Hsp70 after
heat shock (Fig.
2C,D).

View larger version (135K):
[in this window]
[in a new window]
|
Figure 2. Glial cells, but not motor neurons, upregulate Hsp70 after heat shock.
AD, Spinal cord cultures were subjected to 37°C
control temperature (A) or 42°C heat shock
(BD) for 1 hr, followed by 2 hr recovery at 37°C.
Hsp70 induction was assessed by immunocytochemistry using biotin-conjugated
secondary antibodies and DAB as substrate (A, B) or by
fluorescence-conjugated secondary antibodies (C). Heat-shocked spinal
cord cultures were also double labeled with antibodies against GFAP
(D) to verify that glial cells induced Hsp70. The arrow in A
points to a motor neuron. Scale bars: A, B, 50 µm; C, D,
20 µm.
|
|
The absence of Hsp70 induction under these conditions of heat shock could
be attributable to sufficient levels of constitutively expressed HSPs, such as
Hsc70 or Hsp25, thereby obviating induction of the Hsp70 gene. Thus,
different paradigms of heat shock were examined, including higher temperatures
(43°C and 44°C), increasing durations of hyperthermia (up to 8 hr),
and prolonged recovery times (up to 6 hr). Some of these extreme heat shock
conditions caused motor neuron death; however, surviving motor neurons still
failed to induce Hsp70, although expression was detected in other neurons,
including DRG neurons, under these conditions (our unpublished data).
Together, these results indicate that motor neurons have either a weak or
nonexistent stress response after exposure to thermal stress.
Glutamate excitotoxicity did not induce Hsp70 in motor neurons
Glutamate excitotoxicity has been implicated in the pathogenesis of ALS
(for review, see Cleveland and Rothstein,
2001
) both through loss of the astrocytic glutamate transporter
GLT-1 and consequent exposures to higher levels of glutamate
(Rothstein et al., 1995
;
Cleveland and Rothstein, 2001
)
and through increased sensitivity to normally nonlethal levels of glutamate
(Roy et al., 1998
;
Ludolph et al., 2000
). In
previous studies, neuronal cells were protected from glutamate excitotoxicity
by a preconditioning mild heat stress, which induced HSPs
(Lowenstein et al., 1991
;
Rordorf et al., 1991
).
However, the involvement of Hsp70 specifically has depended on the
experimental model. Glutamate induced Hsp70 in neurons of hippocampal slices
(Sato and Matsuki, 2002
) but
not in cerebellar granule neurons
(Lowenstein et al., 1991
).
Overexpression of Hsp70 failed to protect cultured cortical or hippocampal
neurons from glutamate excitotoxicity
(Snider and Choi, 1996
;
Fink et al., 1997
); yet,
knockdown of Hsp70 using antisense oligonucleotides sensitized neurons of
hippocampal slices to glutamate (Sato and
Matsuki, 2002
). To determine whether glutamate can affect the heat
shock response of motor neurons, spinal cord cultures were exposed to
excitotoxic levels of glutamate. In preliminary experiments, motor neuron
death began 30 min after the addition of 50 µM glutamate with
40% cell loss occurring 4 hr later. Spinal cord cultures were treated for
30 min with 25 or 50 µM glutamate and analyzed immediately or
after a 2 hr recovery by immunocytochemistry. No induction of Hsp70 was
observed in motor neurons under these conditions
(Fig. 3C,D). However,
the absence of Hsp70 expression was not because of unresponsiveness of motor
neurons to glutamate, because strong anti-nitrotyrosine labeling, an indicator
of glutamate toxicity (for review, see
Doroudchi et al., 2001
), was
observed (Fig. 3E,F).
Thus, like heat shock, glutamate excitotoxic stress failed to upregulate Hsp70
in motor neurons. By Western blot analysis, glutamate also failed to induce
Hsp70 or alter total levels of Hsp25, Hsc70, and
B-crystallin in spinal
cord cultures (our unpublished data).

View larger version (130K):
[in this window]
[in a new window]
|
Figure 3. Motor neurons failed to express Hsp70 in response to glutamate.
AF, Spinal cord cultures were treated with
50µM glutamic acid (B, D,F) or vehicle (A,
C,E) for 30 min and then assessed for Hsp70 induction by
immunocytochemistry (SPA-810). Nitrotyrosine labeling demonstrated that
glutamate treatment had an effect on motor neurons (E, F). Scale bar,
20 µm
|
|
Expression of G93A SOD-1 in motor neurons did not induce Hsp70
To determine whether expression of the disease-causing mutant protein G93A
SOD-1 results in Hsp70 induction in cultured motor neurons, plasmid expression
vectors encoding wildtype or G93A SOD-1 were microinjected into the nuclei of
motor neurons in primary spinal cord cultures. In this model, motor neuron
loss begins
3 d after microinjection of G93A SOD-1 expression plasmid and
reaches
50% at day five (Durham et
al., 1997
; Roy et al.,
1998
). At these times, Hsp70 expression in motor neurons
expressing wildtype or G93A SOD-1 was compared by double-labeling cultures
with antibodies against Hsp70 and human SOD-1. Hsp70 was detected at low
levels in a small percentage of cells, but there was no significant difference
among those coexpressing wildtype and G93A SOD-1
(Table 1).
Hsp70 expression in motor neurons was also investigated in
B6SJL-TgN(SOD1-G93A)1Gur transgenic mice. Similar to findings in the FALS
culture model, Hsp70 was not detected in motor neurons in lumbar spinal cord
sections by immunohistochemistry at 80, 92, or 115 d of age
(Fig.
4AC). Obvious loss of motor neurons in
the ventral horn was apparent between 92 and 115 d as documented in previous
studies of these mice (Dal Canto and Gurney,
1994
,
1995
;
Chiu et al., 1995
;
Hall et al., 1998
;
Kong and Xu, 1998
). Rarely, an
immunoreactive background cell was observed, indicating that the antibody
could recognize Hsp70 under these experimental conditions.

View larger version (103K):
[in this window]
[in a new window]
|
Figure 4. Expression of HSPs in lumbar spinal cord of G93A mutant SOD-1 transgenic
mice. The 20 µm sections of lumbar spinal cord from 80, 92, and 115-d-old
mice were labeled with antibodies to Hsp70 (SPA-810), Hsp25 (M20; recognizes
primate Hsp27 and rodent Hsp25), GFAP, MAC-1, or B-crystallin. No
induction of Hsp70 was observed (AC). Motor neurons
constitutively expressed Hsp25 (DF), but no
qualitative changes were noted with disease progression. There was a
progressive increase in Hsp25 expressing astrocytes with age
(GI). Motor neurons of 115-d-old nontransgenic mice
constitutively expressed B-crystallin (P). In lumbar cord from
115-d-old symptomatic G93A SOD-1 transgenics, B-crystallin was detected
in some but not all reactive astrocytes (Q,R). Reactive astrocytes
and microglia were identified by expression of GFAP (J, K, L, R) and
MAC-1 (MO) labeling of adjacent sections,
respectively. Scale bars: AC, GR, 40 µm;
DF, 15.4 µm.
|
|
Reactive astrocytes in spinal cords of mutant SOD-1 transgenic mice
upregulated Hsp25
By Western blotting, a significant increase in Hsp25 was observed in lumbar
spinal cord homogenates from symptomatic G93A SOD-1 transgenic mice relative
to age-matched nontransgenic and wild-type SOD-1 transgenic animals
(Fig. 5A). The level
of Hsp25 was also greater in symptomatic, relative to nonsymptomatic, G93A
SOD-1 littermates killed at 115 d of age. Labeling of adjacent spinal cord
sections with antibodies against Hsp25 and GFAP determined that Hsp25 was
localized to reactive astrocytes (Fig.
4GL). This pattern of Hsp25 labeling was
distinct from the microglial marker MAC-1, which also increased with disease
progression (Fig.
4MO). The number of Hsp25-expressing astrocytes
and intensity of labeling increased between 80 and 115 d of age, paralleling
total levels of Hsp25 in spinal cord homogenates
(Fig. 5A) and the time
course of motor neuron loss, microglial infiltration, and clinical progression
of disease (vide supra). At early stages, astrogliosis was restricted
to the ventral gray matter (preclinical phase) and increased progressively
until the end stage of disease (
4 months of age). At the end stage, Hsp25
and GFAP-expressing astrocytes were prominent throughout the gray matter.
Neither astrocytosis nor microglial activation were observed in spinal cords
of nontransgenic littermates or wild-type SOD-1 transgenic mice (our
unpublished data). Constitutive expression of Hsp25 was observed in motor
neurons as reported previously (Plumier et
al., 1997
). However, no qualitative difference in expression was
noted by immunohistochemistry in motor neurons of G93A SOD-1 mice, either with
disease progression (Fig.
4DF) or in comparison with motor neurons of
age-matched wild-type SOD-1 mice or nontransgenic littermates (our unpublished
data).
B-crystallin was detected by immunohistochemistry in motor neurons
as well as unidentified cells throughout the neuropil but appeared similar in
all lines of transgenic mice (Fig.
4P,Q). In the spinal cord from symptomatic G93A SOD-1
mice, a sub-population of reactive astrocytes expressed
B-crystallin
(Fig. 4Q,R). However,
this was at a much lesser extent than that seen with Hsp25 and was not
sufficient to be reflected on Western blots, which showed similar
B-crystallin levels among all groups
(Fig. 5B).
The above findings in the B6SJL-TgN(SOD1-G93A)1Gur transgenic mouse line
were confirmed in mice from the B6.Cg-TgN(SOD1-G93A)dl 1Gur
[PDB]
lineage
which exhibits slower disease progression (our unpublished data).
Neither Hsp70 nor Hsp27 are upregulated in spinal cords from familial
and sporadic ALS patients
To determine whether the findings in transgenic mice could be extended to
ALS patients, HSP expression was assessed by immunohistochemistry in the
cervical spinal cord obtained at autopsy from patients with sporadic ALS
(three cases), FALS (three cases, one of which harbored the A4V SOD-1
mutation), and two control cases. Motor neurons in sections of the cervical
spinal cord obtained from ALS patients
(Fig. 6 D) were not
labeled by anti-Hsp70. Glial immunoreactivity was occasionally observed in
other parts of neuropil, indicating that this antibody can recognize Hsp70
when used for this procedure (our unpublished data).

View larger version (173K):
[in this window]
[in a new window]
|
Figure 6. HSP expression in cervical spinal cord of control, sporadic, and FALS (A4V
SOD-1 mutation). Hsp27 was detected in spinal motor neurons and neuritic
processes in the anterior horn of control (A), sporadic (B),
and FALS (C) patients; the arrow in C points to a spinal
motor neuron containing a Bunina body. Hsp70 immunolabeling was not observed
in the cytoplasm of motor neurons of FALS (D) or sporadic ALS (our
unpublished data). Hsp27 labeling in the neuropil (E) does not
correspond to the pattern of GFAP immunoreactivity (F). Scale bars:
A, 100 µm; B, 40 µm; CF, 20
µm.
|
|
Consistent with observations in transgenic mice, constitutive expression of
the human Hsp27 isoform, equivalent to mouse Hsp25, was observed in motor
neurons of control (Fig.
6A), sporadic ALS
(Fig. 6B), and FALS
(Fig. 6C) cases.
However, unlike the G93A SOD-1 transgenic mice, high expression of Hsp27 in
reactive astrocytes was not detected in spinal cords from either sporadic or
FALS patients (Fig.
6C). Hsp27 immunoreactivity appeared localized to motor
neuronal cell bodies and neurites rather than coincident with areas of
reactive gliosis. Analysis of the background neuropil indicated that Hsp27
labeling (Fig. 6E) did
not arise from morphologically typical astrocytes immunolabeled with anti-GFAP
(Fig. 6F).
Thus, motor neurons of ALS patients failed to express Hsp70, consistent
with findings in primary culture and transgenic mouse experimental models.
However, the increase in Hsp25 in reactive astrocytes in G93A SOD-1 transgenic
mice was not replicated in the spinal cord of patients with familial or
sporadic ALS.
Motor neurons expressed the major heat shock transcription factors HSF1
and HSF2
To determine whether the failure of motor neurons to induce Hsp70 after
heat shock, glutamate, or mutant SOD-1 expression was attributable to lack of
HSF, expression of the two major mammalian HSFs, HSF1 and HSF2, was assessed
in spinal cord cultures. HSF1 primarily controls transcriptional activation of
HSP genes in response to environmental stress by binding to HSEs on HSP
promoters as trimers and undergoing hyperphosphorylation
(Morimoto, 1998
). HSF2 has a
high turnover rate because of proteasome-mediated degradation
(Mathew et al., 1998
). When
proteasome activity is inhibited sufficiently, HSF2 accumulates, forms
trimers, translocates to the nucleus, and binds to HSEs, events associated
with de novo transcription of HSP genes
(Mathew et al., 1998
).
In untreated spinal cord cultures, motor neurons and other cells were
labeled by a monoclonal antibody to HSF1, which preferentially labeled nuclei
(Fig. 7A). HSF2 was
not detected in untreated cultures but accumulated in the nuclei of motor
neurons and other spinal cord cells after overnight incubation with proteasome
inhibitor MG132 (0.11 µM)
(Fig. 7B2) as reported
previously in cell lines (Mathew et al.,
1998
). In addition to increasing levels of HSF2, MG132 induced
strong expression of Hsp70 in motor neurons and other spinal cord cells
(Fig. 7B4). Similar
results were obtained with a more specific proteasome inhibitor, lactacystin
(110 µM; Calbiochem, La Jolla, CA) (our unpublished
data). Hence, Hsp70 induction can occur in motor neurons under conditions of
decreased proteasome activity or via downstream effects of proteasome
inhibition.

View larger version (91K):
[in this window]
[in a new window]
|
Figure 7. Motor neurons express the heat shock transcription factors HSF1 and HSF2.
A, Motor neurons and other cells in primary spinal cord cultures were
labeled by a monoclonal antibody to HSF1 (SPA-950). B, Overnight
treatment with the proteasomal inhibitor MG132 (0.1 µM) caused
HSF2 to accumulate and translocate into the nuclei of spinal cord cells,
including motor neurons (1,2).In motor neurons and other cells treated with
MG132 (1µM), strong Hsp70 (SPA-810) expression was also detected
by immunocytochemistry using DAB as substrate (3,4). Arrows indicate motor
neurons. Scale bar, 30 µm.
|
|
Activation of HSF1 caused strong induction of markers of the heat
shockstress response in motor neurons
To address the possibility that motor neurons do not have sufficient
amounts of HSF1 to mount a heat shock response, HSF1wt was
overexpressed in motor neurons, and Hsp70 induction was assessed after heat
stress. Motor neurons were microinjected with a plasmid-encoding
HSF1wt, allowed to recover for 48 hr, and incubated at 42°C or
37°C for 1 hr and then 2 hr at 37°C. These conditions of heat shock
were the same as those used in experiments shown in
Figure 2, but again, no
increase in Hsp70 expression was detected before or after heat shock, despite
clear overexpression of HSF1wt in motor neurons
(Fig. 8A1,5). In
contrast, robust Hsp70 expression was observed at 37°C in motor neurons
injected with plasmid encoding a constitutively activated form of HSF1
(HSF1(+)) (Fig.
8A3,7) but not an inactivatable form (HSF1(-))
(Fig. 8A4,8).
HSF1(+) has a deletion of amino acids 202316, which changes
the conformation of the protein rendering HSF1 constitutively active and
eliminating the requirement for phosphorylation of serine residues in this
region. HSF1(-) has a deletion of amino acids 453523
spanning the transcriptional activation domain. Hsp70 induction in motor
neurons injected with HSF1(+) was consistently intense
(Fig. 8A7, B, top,
). In the occasional Hsp70-immunopositive motor neuron expressing
HSF1wt or HSF1(-), labeling was of relatively low
intensity and frequently localized to the nucleus
(Fig. 8B, middle,
). Not only did HSF1(+) cause stronger expression of Hsp70
(Fig. 8A7), it also
caused a significant increase in the number of cells that induced Hsp70
(Fig. 8B).

View larger version (51K):
[in this window]
[in a new window]
|
Figure 8. Expression of activated HSF1, but not HSF1 wt, by gene transfer
induces HSP70 expression in motor neurons. A, B, Motor neurons were
microinjected with plasmid expression vectors encoding HSF1 wt,
constitutively activated HSF1 (HSF1 (+)), or nonactivatable HSF1
(HSF1 (-)). After 48 hr, motor neurons injected with HSF1
wt were heat shocked (42°C; 1 hr) or subjected to control
conditions (37°C; 1 hr) and recovered at 37°C for 2 hr. All cultures
were double labeled with antibodies against HSF1 and Hsp70. A,
Although motor neurons expressed HSF1 wt (1,2) at levels comparable
with HSF1 (+) (3), only HSF1 (+) induced Hsp70
(57). B, Percentage of motor neurons coexpressing HSF1 and
Hsp70 (n 4 cultures per group). Intense Hsp70 immunolabeling
( ) occurred only in motor neurons injected with
HSF1(+). In the other three conditions, lower intensity
labeling was observed frequently in the nucleus ( ). Only HSF1
(+) significantly increased the percentage of motor neurons
expressing Hsp70 (t test; one-tailed; unequal variance; p
< 0.0001). C, HSF1 (+) also caused strong expression of
a GFP reporter gene under the control of the Hsp70 promoter in motor neurons.
Left, Motor neurons injected with the dextran TMR marker and GFP vector were
imaged before and 2 hr after heat shock. Right, Heat shock failed to induce
GFP (5), in contrast to coexpression of HSF1 (+), which resulted in
strong GFP expression (6). Scale bar, 30 µm.
|
|
Similar results were obtained using a GFP reporter gene driven by the human
Hsp70 promoter (pEGFP-HSE-GFP). Motor neurons were coinjected with this vector
along with the red fluorescent marker, 70 kDa dextran TMR. The following day,
motor neurons were imaged for TMR and GFP fluorescence
(Fig. 8C) before heat
shock (42°C, 1 hr) and (in the same cells) after 2, 10, and 24 hr recovery
at 37°C. GFP expression was never observed in motor neurons at any of the
recovery times (Fig.
8C4,5). However, when HSF1(+) vector
was coinjected with pEGFP-HSE-GFP, strong induction of GFP was observed in
motor neurons (Fig.
8C6). Thus, even with a high level of expression of
wtHSF1, thermal stress failed to activate heat shock gene transcription, but
bypassing the normal mechanisms of transcriptional activation resulted in
expression of two different proteins under the control of the Hsp70
promoter.
 |
Discussion
|
|---|
The results demonstrate that motor neurons have a high threshold for
induction of the heat shock response. Although glia in primary spinal cord
cultures upregulated the major stress-inducible protein Hsp70, after heat
shock, motor neurons failed to express Hsp70 when subjected to hyperthermia,
glutamate excitotoxicity, or expression of mutant SOD-1. Also, cultured motor
neurons microinjected with a GFP reporter gene driven by the Hsp70 promoter
failed to induce GFP after heat shock. No induction of Hsp70 was observed in
spinal motor neurons in two lines of G93A mutant SOD-1 transgenic mice or in
patients with ALS.
Because different stressors can induce expression of different HSPs, Hsp25
and
B-crystallin were also monitored. Although endogenous expression of
both proteins was detected in the cytoplasm of motor neurons in culture and
in vivo, no qualitative differences were observed after stress
treatments in culture, G93A SOD-1 transgenic mice throughout the disease
course, or ALS spinal cords. Recently, increased Hsp25 was reported in nuclei
of motor neurons in G93A SOD-1 transgenic mice
(Vleminckx et al., 2002
). This
was not observed in the present study, although mice were killed at an earlier
stage of clinical disease. Consistent with the findings of Vleminckx et al.
(2002
), Hsp25 and, to a lesser
extent,
B-crystallin were increased in spinal cord homogenates of G93A
SOD-1 mice in parallel with disease progression. By immunohistochemistry,
increased Hsp25 was particularly evident in reactive astrocytes, which may
represent a common event during reactive astrocytosis or a stress response to
mutant SOD-1 toxicity. Studies in other rodent models of injury and human
disease have demonstrated increased astrocytic Hsp25
(Manzerra and Brown, 1992
;
Shinohara et al., 1993
;
Renkawek et al., 1994
;
Satoh and Kim, 1995
;
Marcuccilli et al., 1996
;
Krueger et al., 1999
;
Mautes and Noble, 2000
).
However, the significance of astrocytic Hsp25 to ALS is questioned because
upregulation of the human homolog Hsp27 was not observed in the spinal cord of
ALS patients, despite demonstration of gliosis by GFAP immunolabeling. Whether
the difference is related to species, the HSPs investigated, specific toxicity
of the G93A SOD-1 mutation, and disease pathogenesis in mouse models versus
human patients remains to be determined.
Neurons, in general, show a higher threshold for induction of the stress
response than astrocytes; yet, evidence points to motor neurons having a
particularly high threshold for induction of Hsp70. DRG sensory neurons and
other neurons in spinal cordDRG culture expressed Hsp70 after heat
shock at temperatures >42°C but motor neurons did not (our unpublished
data). Other studies have shown that spinal motor neurons in situ
failed to induce Hsp70 after heat shock
(Manzerra and Brown, 1992
;
Brown and Rush, 1999
) and
spinal cord contusion (Mautes and Noble,
2000
) in contrast with other types of neurons, such as cerebellar,
cortical, and pyramidal, which upregulated Hsp70 after heat shock
(Lowenstein et al., 1991
;
Bechtold et al., 2000
) and in
different ischemic paradigms (Krueger et
al., 1999
; Currie et al.,
2000
). Although sciatic nerve axotomy increased Hsp25 in adult rat
motor neurons (Costigan et al.,
1998
; Benn et al.,
2002
), in transgenic models of motor neuron disease, Hsp25
appeared unchanged (in the present study), was increased in nuclei
(Vleminckx et al., 2002
), or
decreased (Pieri et al.,
2001
).
Exposure of motor neurons to hyperthermia would be expected to activate
heat shock gene expression primarily through HSF1
(Morimoto, 1998
). Inactive
HSF1 can be found: (1) as a monomer in the cytoplasm, forming transient
associations with Hsp70 and Hsp90
(Morimoto and Santoro, 1998
),
and (2) in nuclear granules (Cotto et al.,
1997
; Jolly et al.,
2002
). When levels of HSPs are insufficient in stressed cells,
HSF1 trimerizes, binds to HSEs, and undergoes phosphorylation at multiple
sites. This changes its conformation, recruiting the transcriptional machinery
at HSP promoters and culminating in transactivation of heat shock genes
(Morimoto and Santoro, 1998
;
Holmberg et al., 2001
). Thus,
arrest of HSP induction in motor neurons could occur at the level of HSF1
expression, trimerization of the transcription factor, binding to HSEs,
phosphorylationactivation of HSF1, or HSP mRNA stability, processing,
and/or translation.
The failure of hippocampal neurons to induce Hsp70 after heat shock was
attributed to a lack of HSF1 (Marcuccilli
et al., 1996
). Motor neurons did express HSF1, but it was still
possible that they did not express sufficient levels to mount a heat shock
response or that immunolabeling did not reflect the true state. However, when
the level of HSF1wt was increased in motor neurons, heat shock
still failed to induce Hsp70. This experiment demonstrated that the block in
stress-induced expression of Hsp70 in motor neurons was not at the level of
HSF1 expression.
Previous studies had implicated faster disassembly of hyperphosphorylated
HSF1 trimers in the failure of Scrapie to induce Hsp70 in ScN2a neuroblastoma
cells (Winklhofer et al.,
2001
), and the inability of HSF1 to bind to the Hsp70
promoter in the reduced ability of retinoblastoma Y79 cells to transcribe
Hsp70 after heat shock (Mathur et
al., 1994
). However, a constitutively active form of HSF1,
HSF1(+), but not the inactivatable form, HSF1(-),
induced strong Hsp70 when expressed in cultured motor neurons. For
HSF1(+) to have transactivated gene expression, trimerization,
nuclear transport, and binding to HSE must have occurred. Although this could
not be assessed directly in single cells of dissociated spinal cord cultures,
it has been demonstrated in cell lines that HSF1wt,
HSF1(+), and HSF1(-) oligomerize and bind to HSEs, but
only HSF1(+) causes transactivation of HSP genes in the absence of
stress. Heat shock was required for HSF1wt to transactivate HSP
gene expression (Zuo et al.,
1995
).
In addition to Hsp70, HSF1(+) induced expression of a GFP
reporter under the control of the Hsp70 promoter. This result and the increase
in Hsp70 after HSF1(+) gene transfer indicate that once the
HSFHSE complex was activated, transcription and translation
proceeded.
The most likely cause of the failure of motor neurons to induce a stress
response involves alterations in the signaling pathways that regulate HSF1
activation. HSF1(+) has a deletion spanning amino acids
202316, a region harboring numerous serine residues, the
phosphorylation states of which regulate the transactivational competence of
HSF1 by altering its conformation (Zuo et
al., 1995
). Deletion of this domain changes the conformation of
HSF1, rendering it constitutively active and obviating the requirement for
phosphorylation. Within this region, constitutive phosphorylation at serines
303 and 307 by glycogen synthase kinase 3
and extracellular
signal-regulated kinase (Chu et al.,
1996
) represses transcriptional activity of HSF1, implicating
dephosphorylation at these sites in HSF1 activation. Stress-inducible
phosphorylation of another residue within this domain, serine 230, which lies
within a consensus site for calciumcalmodulin kinase II, is a key
phosphorylation event resulting in HSF1 activation
(Holmberg et al., 2001
). Lack
of activation or changes in the regulation of these candidate kinases could be
responsible for the deficiency in the heat shockstress response
observed in motor neurons.
In contrast to heat shock, glutamate excitotoxicity, and expression of
mutant SOD-1, peptide inhibitors of proteasome activity induced robust
expression of Hsp70 in motor neurons concomitant with accumulation and nuclear
localization of the transcription factor HSF2. This result is consistent with
the role for HSF2 in HSP gene transcription
(Mathew et al., 1998
).
Proteasome inhibition has been implicated in disorders characterized by
protein aggregation, including trinucleotide repeat diseases
(Bence et al., 2001
;
Sherman and Goldberg, 2001
).
Mutant SOD-1 also undergoes degradation in proteasomes
(Hoffman et al., 1996
;
Johnston et al., 2000
), and
recent studies demonstrated decreased proteasome activity in cell lines
expressing mutant SOD-1 (Hyun et al.,
2002
; Urushitani et al.,
2002
) and lumbar spinal cord from G93A SOD-1 transgenic mice (our
unpublished data). Low levels of HSF2 are maintained by proteasomal
degradation (see Results). If mutant SOD-1 had abrogated proteasome function,
accumulation of HSF2 and transactivation of Hsp70 would be expected,
but neither was observed in cultured motor neurons expressing G93A SOD-1 (our
unpublished data) (Table 1) nor
in motor neurons in lumbar spinal cord of G93A mice (our unpublished data)
(Fig.
5AC). However, neither the threshold
level of proteasome inhibition required for HSF2 accumulation nor the
requirement of other factors, such as the HSF2 modulator, SUMO-1
(Goodson et al., 2001
), are
known. Proteasome inhibition also increases HSF1 activation, presumably by
reduced proteolysis of HSF1-targeting kinase(s)
(Holmberg et al., 2001
). The
level of proteasome inhibition by mutant SOD-1 may not be sufficient to induce
Hsp70 via either HSF2 accumulation or HSF1 activation.
In conclusion, our results indicate that the impaired ability of motor
neurons to mount a heat shockstress response occurs at the level of
activation of HSF1, the major cellular stress sensor. This feature, in
addition to other factors, such as neurofilament organization, high level of
glutamatergic input, expression of calcium-permeable AMPA receptors, and low
levels of free radical scavengers and cytosolic calcium-binding proteins (for
review, see Roy et al., 1998
),
may contribute to their preferential vulnerability to disease. Preliminary
studies indicate that expression of constitutively activated HSF1 protects
motor neurons from mutant SOD-1 toxicity (our unpublished data), supporting
the possibility that pharmacological activation of HSF1 in motor neurons may
overcome the deleterious effects of other disease-related and environmental
stresses.
 |
Footnotes
|
|---|
Received Mar. 3, 2003;
revised Apr. 14, 2003;
accepted Apr. 21, 2003.
This research was supported by the Canadian Institutes for Health Research,
the ALS Society of Canada, and the ALS Association. We thank Dr. R. I.
Morimoto for helpful discussion, the HSF2 antibody, and HSEGFP reporter
construct, Dr. R. Voellmy for the HSF1 constructs, Dr. S. David for the MAC-1
antibody, Emily Tam for assistance with MG132 experiments, and Dr. P.
McPherson for assistance with GFP imaging.
Correspondence should be addressed to Dr. Heather D. Durham, Montreal
Neurological Institute, 3801 University Street, Montreal, Quebec, Canada H3A
2B4. E-mail:
heather.durham{at}mcgill.ca.
Copyright © 2003 Society for Neuroscience
0270-6474/03/235789-10$15.00/0
 |
References
|
|---|
Bechtold DA, Rush SJ, Brown IR (2000) Localization of
the heat-shock protein Hsp70 to the synapse following hyperthermic stress in
the brain. J Neurochem 74:
641-646.[Medline]
Bence NF, Sampat RM, Kopito RR (2001) Impairment of
the ubiquitin-proteasome system by protein aggregation. Science
292: 1552-1555.[Abstract/Free Full Text]
Benn SC, Perrelet D, Kato AC, Scholz J, Decosterd I, Mannion RJ,
Bakowska JC, Woolf CJ (2002) Hsp27 upregulation and
phosphorylation is required for injured sensory and motor neuron survival.
Neuron 36:
45-56.[Web of Science][Medline]
Brown IR, Rush SJ (1999) Cellular localization of the
heat shock transcription factors HSF1 and HSF2 in the rat brain during
postnatal development and following hyperthermia. Brain Res
821: 333-340.[Medline]
Bruening W, Roy J, Giasson B, Figlewicz DA, Mushynski WE, Durham HD
(1999) Up-regulation of protein chaperones preserves viability of
cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with
amyotrophic lateral sclerosis. J Neurochem
72: 693-699.[Web of Science][Medline]
Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG,
Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW
(1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes
and promotes rapidly progressive disease with SOD1-containing inclusions.
Neuron 18:
327-338.[Web of Science][Medline]
Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM,
Gurney ME (1995) Age-dependent penetrance of disease in a
transgenic mouse model of familial amyotrophic lateral sclerosis. Mol
Cell Neurosci 6:
349-362.[Web of Science][Medline]
Chu B, Soncin F, Price BD, Stevenson MA, Calderwood SK
(1996) Sequential phosphorylation by mitogen-activated protein
kinase and glycogen synthase kinase 3 represses transcriptional activation by
heat shock factor-1. J Biol Chem 271:
30847-30857.[Abstract/Free Full Text]
Cleveland DW, Rothstein JD (2001) From Charcot to Lou
Gehrig: deciphering selective motor neuron death in ALS. Nat Rev
Neurosci 2:
806-819.[Web of Science][Medline]
Costigan M, Mannion RJ, Kendall G, Lewis SE, Campagna JA,
Coggeshall RE, Meridith-Middleton J, Tate S, Woolf CJ (1998) Heat
shock protein 27: developmental regulation and expression after peripheral
nerve injury. J Neurosci 18:
5891-5900.[Abstract/Free Full Text]
Cotto J, Fox S, Morimoto R (1997) HSF1 granules: a
novel stress-induced nuclear compartment of human cells. J Cell
Sci 110:
2925-2934.[Abstract]
Currie RW, Ellison JA, White RF, Feuerstein GZ, Wang X, Barone FC
(2000) Benign focal ischemic preconditioning induces neuronal
Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain
Res 863:
169-181.[Web of Science][Medline]
Dal Canto MC, Gurney ME (1994) Development of central
nervous system pathology in a murine transgenic model of human amyotrophic
lateral sclerosis. Am J Pathol 145:
1271-1279.[Abstract]
Dal Canto MC, Gurney ME (1995) Neuropathological
changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD,
and in mice overexpressing wild type human SOD: a model of familial
amyotrophic lateral sclerosis (FALS). Brain Res
676: 25-40.[Web of Science][Medline]
Deng H-X, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung W-Y,
Getzoff ED, Hu P, Herzfeldt B, Roos RP, Warner C, Deng G, Soriano E, Smyth C,
Parge HE, Ahmed A, Roses AD, Hallewell RA, Pericak-Vance MA, Siddique T
(1993) Amyotrophic lateral sclerosis and structural defects in
Cu, Zn Superoxide dismutase. Science
261: 1047-1051.[Abstract/Free Full Text]
Doroudchi MM, Minotti S, Figlewicz DA, Durham HD
(2001) Nitrotyrosination contributes minimally to toxicity of
mutant SOD1 associated with ALS. NeuroReport
12: 1239-1243.[Medline]
Durham HD, Roy J, Dong L, Figlewicz DA (1997)
Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model
of ALS. J Neuropathol Exp Neurol 56:
523-530.[Web of Science][Medline]
Fink SL, Chang LK, Ho DY, Sapolsky RM (1997) Defective
herpes simplex virus vectors expressing the rat brain stress-inducible heat
shock protein 72 protect cultured neurons from severe heat shock. J
Neurochem 68:
961-969.[Web of Science][Medline]
Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI,
Sherman MY (1997) Hsp70 prevents activation of stress kinases. A
novel pathway of cellular thermotolerance. J Biol Chem
272: 18033-18037.[Abstract/Free Full Text]
Goodson ML, Hong Y, Rogers R, Matunis MJ, Park-Sarge OK, Sarge KD
(2001) Sumo-1 modification regulates the DNA binding activity of
heat shock transcription factor 2, a promyelocytic leukemia nuclear body
associated transcription factor. J Biol Chem
276: 18513-18518.[Abstract/Free Full Text]
Hall ED, Oostveen JA, Gurney ME (1998) Relationship of
microglial and astrocytic activation to disease onset and progression in a
transgenic model of familial ALS. Glia
23: 249-256.[Web of Science][Medline]
Hoffman EK, Wilcox HM, Scott RW, Siman R (1996)
Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide
dismutase with mutations linked to familial amyotrophic lateral sclerosis.
J Neurol Sci 139:
15-20.[Web of Science][Medline]
Holmberg CI, Hietakangas V, Mikhailov A, Rantanen JO, Kallio M,
Meinander A, Hellman J, Morrice N, MacKintosh C, Morimoto RI, Eriksson JE,
Sistonen L (2001) Phosphorylation of serine 230 promotes
inducible transcriptional activity of heat shock factor 1. EMBO
J 20:
3800-3810.[Web of Science][Medline]
Hyun DH, Lee MH, Halliwell B, Jenner P (2002)
Proteasomal dysfunction induced by 4-hydroxy-2, 3-trans-nonenal, an
end-product of lipid peroxidation: a mechanism contributing to
neurodegeneration? J Neurochem 83:
360-370.[Web of Science][Medline]
Johnston JA, Dalton MJ, Gurney ME, Kopito RR (2000)
Formation of high molecular weight complexes of mutant Cu, Zn-superoxide
dismutase in a mouse model for familial amyotrophic lateral sclerosis.
Proc Natl Acad Sci USA 97:
12571-12576.[Abstract/Free Full Text]
Jolly C, Konecny L, Grady DL, Kutskova YA, Cotto JJ, Morimoto RI,
Vourc'h C (2002) In vivo binding of active heat shock
transcription factor 1 to human chromosome 9 heterochromatin during stress.
J Cell Biol 156:
775-781.[Abstract/Free Full Text]
Kong J, Xu Z (1998) Massive mitochondrial degeneration
in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice
expressing a mutant SOD1. J Neurosci 18:
3241-3250.[Abstract/Free Full Text]
Krueger AM, Armstrong JN, Plumier J, Robertson HA, Currie RW
(1999) Cell specific expression of Hsp70 in neurons and glia of
the rat hippocampus after hyperthermia and kainic acid-induced seizure
activity. Brain Res Mol Brain Res 71:
265-278.[Medline]
Lowenstein DH, Chan PH, Miles MF (1991) The stress
protein response in cultured neurons: characterization and evidence for a
protective role in excitotoxicity. Neuron
7: 1053-1060.[Web of Science][Medline]
Ludolph AC, Meyer T, Riepe MW (2000) The role of
excitotoxicity in ALSwhat is the evidence? J Neurol
247: 7-16.[Medline]
Manzerra P, Brown IR (1992) Expression of heat shock
genes (hsp70) in the rabbit spinal cord: localization of constitutive and
hyperthermia-inducible mRNA species. J Neurosci Res
31: 606-615.[Web of Science][Medline]
Marcuccilli CJ, Mathur SK, Morimoto RI, Miller RJ
(1996) Regulatory differences in the stress response of
hippocampal neurons and glial cells after heat shock. J
Neurosci 16:
478-485.[Abstract/Free Full Text]
Mathew A, Mathur SK, Morimoto RI (1998) Heat shock
response and protein degradation: regulation of HSF2 by the
ubiquitin-proteasome pathway. Mol Cell Biol
18: 5091-5098.[Abstract/Free Full Text]
Mathur SK, Sistonen L, Brown IR, Murphy SP, Sarge KD, Morimoto RI
(1994) Deficient induction of human hsp70 heat shock gene
transcription in Y79 retinoblastoma cells despite activation of heat shock
factor 1. Proc Natl Acad Sci USA 91:
8695-8699.[Abstract/Free Full Text]
Mautes AE, Noble LJ (2000) Co-induction of HSP70 and
heme oxygenase-1 in macrophages and glia after spinal cord contusion in the
rat. Brain Res 883:
233-237.[Medline]
Meriin AB, Yaglom JA, Gabai VL, Zon L, Ganiatsas S, Mosser DD, Zon
L, Sherman MY (1999) Protein-damaging stresses activate c-Jun
N-terminal kinase via inhibition of its dephosphorylation: a novel pathway
controlled by HSP72. Mol Cell Biol 19:
2547-2555.[Abstract/Free Full Text]
Min JN, Han MY, Lee SS, Kim KJ, Park YM (2000)
Regulation of rat heat shock factor 2 expression during the early organogenic
phase of embryogenesis. Biochim Biophys Acta
1494: 256-262.[Medline]
Morimoto RI (1998) Regulation of the heat shock
transcriptional response: cross talk between a family of heat shock factors,
molecular chaperones, and negative regulators [Rev]. Genes Dev
12: 3788-3796.[Free Full Text]
Morimoto RI, Santoro MG (1998) Stress-inducible
responses and heat shock proteins: new pharmacologic targets for
cytoprotection. Nat Biotechnol 16:
833-838.[Web of Science][Medline]
Morimoto RI, Kline MP, Bimston DN, Cotto JJ (1997) The
heat-shock response: regulation and function of heat-shock proteins and
molecular chaperones. Essays Biochem 32:
17-29.[Web of Science][Medline]
Pieri I, Cifuentes-Diaz C, Oudinet JP, Blondet B, Rieger F, Gonin
S, Arrigo AP, Thomas Y (2001) Modulation of HSP25 expression
during anterior horn motor neuron degeneration in the paralyse mouse mutant.
J Neurosci Res 65:
247-253.[Medline]
Plumier JC, Hopkins DA, Robertson HA, Currie RW (1997)
Constitutive expression of the 27-kDa heat shock protein (Hsp27) in sensory
and motor neurons of the rat nervous system. J Comp Neurol
384: 409-428.[Web of Science][Medline]
Renkawek K, Voorter CE, Bosman GJ, van Workum FP, de Jong WW
(1994) Expression of alpha B-crystallin in Alzheimer's disease.
Acta Neuropathol (Berl) 87:
155-160.[Medline]
Rordorf G, Koroshetz WJ, Bonventre JV (1991) Heat
shock protects cultured neurons from glutamate toxicity. Neuron
7: 1043-1051.[Web of Science][Medline]
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A,
Donaldson D, Goto J, O'Regan JP, Deng HX (1993) Mutations in
Cu/Zn superoxide dismutase gene are associated with familial amyotrophic
lateral sclerosis. Nature 362:
59-62.[Medline]
Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW
(1995) Selective loss of glial glutamate transporter GLT-1 in
amyotrophic lateral sclerosis. Ann Neurol
38: 73-84.[Web of Science][Medline]
Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD
(1998) Glutamate potentiates the toxicity of mutant
Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent
mechanisms. J Neurosci 18:
9673-9684.[Abstract/Free Full Text]
Sato K, Matsuki N (2002) A 72 kDa heat shock protein
is protective against the selective vulnerability of CA1 neurons and is
essential for the tolerance exhibited by CA3 neurons in the hippocampus.
Neuroscience 109:
745-756.[Web of Science][Medline]
Satoh JI, Kim SU (1995) Differential expression of
heat shock protein HSP27 in human neurons and glial cells in culture. J
Neurosci Res 41:
805-818.[Medline]
Sherman MY, Goldberg AL (2001) Cellular defenses
against unfolded proteins: a cell biologist thinks about neurodegenerative
diseases. Neuron 29:
15-32.[Web of Science][Medline]
Shinder GA, Lacourse MC, Minotti S, Durham HD (2001)
Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and
interact with heat shock/stress proteins in models of amyotrophic lateral
sclerosis. J Biol Chem 276:
12791-12796.[Abstract/Free Full Text]
Shinohara H, Inaguma Y, Goto S, Inagaki T, Kato K
(1993) Alpha B crystallin and HSP28 are enhanced in the cerebral
cortex of patients with Alzheimer's disease. J Neurol Sci
119: 203-208.[Web of Science][Medline]
Snider BJ, Choi DW (1996) Heat stress reduces
glutamate toxicity in cultured neurons without hsp70 expression. Brain
Res 729:
273-276.[Medline]
Uney JB, Kew JN, Staley K, Tyers P, Sofroniew MV
(1993) Transfection-mediated expression of human Hsp70i protects
rat dorsal root ganglian neurones and glia from severe heat stress.
FEBS Lett 334:
313-316.[Medline]
Urushitani M, Kurisu J, Tsukita K, Takahashi R (2002)
Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces
selective motor neuron death in familial amyotrophic lateral sclerosis.
J Neurochem 83:
1030-1042.[Web of Science][Medline]
Vleminckx V, Van Damme P, Goffin K, Delye H, Van Den BL, Robberecht
W (2002) Upregulation of HSP27 in a transgenic model of ALS.
J Neuropathol Exp Neurol 61:
968-974.[Web of Science][Medline]
Winklhofer KF, Reintjes A, Hoener MC, Voellmy R, Tatzelt J
(2001) Geldanamycin restores a defective heat shock response
in vivo. J Biol Chem 276:
45160-45167.[Abstract/Free Full Text]
Yenari MA, Fink SL, Sun GH, Chang LK, Patel MK, Kunis DM, Onley D,
Ho DY, Sapolsky RM, Steinberg GK (1998) Gene therapy with HSP72
is neuroprotective in rat models of stroke and epilepsy. Ann
Neurol 44:
584-591.[Web of Science][Medline]
Zuo J, Rungger D, Voellmy R (1995) Multiple layers of
regulation of human heat shock transcription factor 1. Mol Cell
Biol 15:
4319-4330.[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
C. L. Simpson, R. Lemmens, K. Miskiewicz, W. J. Broom, V. K. Hansen, P. W.J. van Vught, J. E. Landers, P. Sapp, L. Van Den Bosch, J. Knight, et al.
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration
Hum. Mol. Genet.,
February 1, 2009;
18(3):
472 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Morimoto
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Genes & Dev.,
June 1, 2008;
22(11):
1427 - 1438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. V. Ilieva, V. Ayala, M. Jove, E. Dalfo, D. Cacabelos, M. Povedano, M. J. Bellmunt, I. Ferrer, R. Pamplona, and M. Portero-Otin
Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis
Brain,
December 1, 2007;
130(12):
3111 - 3123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Gifondorwa, M. B. Robinson, C. D. Hayes, A. R. Taylor, D. M. Prevette, R. W. Oppenheim, J. Caress, and C. E. Milligan
Exogenous Delivery of Heat Shock Protein 70 Increases Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
J. Neurosci.,
November 28, 2007;
27(48):
13173 - 13180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Taylor, B. F. Gibbs, E. Kabashi, S. Minotti, H. D. Durham, and J. N. Agar
Tryptophan 32 Potentiates Aggregation and Cytotoxicity of a Copper/Zinc Superoxide Dismutase Mutant Associated with Familial Amyotrophic Lateral Sclerosis
J. Biol. Chem.,
June 1, 2007;
282(22):
16329 - 16335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Falk, T. E. Karlsson, S. Kurdija, J. Frisen, and J. Zupicich
High-Throughput Identification of Genes Promoting Neuron Formation and Lineage Choice in Mouse Embryonic Stem Cells
Stem Cells,
June 1, 2007;
25(6):
1539 - 1545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. MILLER and R. MITTLER
Could Heat Shock Transcription Factors Function as Hydrogen Peroxide Sensors in Plants?
Ann. Bot.,
August 1, 2006;
98(2):
279 - 288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Phanvijhitsiri, M. W. Musch, M. J. Ropeleski, and E. B. Chang
Heat induction of heat shock protein 25 requires cellular glutamine in intestinal epithelial cells
Am J Physiol Cell Physiol,
August 1, 2006;
291(2):
C290 - C299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Traynor, L. Bruijn, R. Conwit, F. Beal, G. O'Neill, S. C. Fagan, and M. E. Cudkowicz
Neuroprotective agents for clinical trials in ALS: A systematic assessment.
Neurology,
July 11, 2006;
67(1):
20 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Shen, J.-C. He, Y. Wang, Q.-Y. Huang, and J.-F. Chen
Geldanamycin Induces Heat Shock Protein 70 and Protects against MPTP-induced Dopaminergic Neurotoxicity in Mice
J. Biol. Chem.,
December 2, 2005;
280(48):
39962 - 39969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Choudry and M. E. Cudkowicz
Clinical Trials in Amyotrophic Lateral Sclerosis: The Tenuous Past and the Promising Future
J. Clin. Pharmacol.,
December 1, 2005;
45(12):
1334 - 1344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Magrane, K. M. Rosen, R. C. Smith, K. Walsh, G. K. Gouras, and H. W. Querfurth
Intraneuronal {beta}-Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response
J. Neurosci.,
November 23, 2005;
25(47):
10960 - 10969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Katsuno, C. Sang, H. Adachi, M. Minamiyama, M. Waza, F. Tanaka, M. Doyu, and G. Sobue
Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease
PNAS,
November 15, 2005;
102(46):
16801 - 16806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tiwari, Z. Xu, and L. J. Hayward
Aberrantly Increased Hydrophobicity Shared by Mutants of Cu,Zn-Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis
J. Biol. Chem.,
August 19, 2005;
280(33):
29771 - 29779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tummala, C. Jung, A. Tiwari, C. M. J. Higgins, L. J. Hayward, and Z. Xu
Inhibition of Chaperone Activity Is a Shared Property of Several Cu,Zn-Superoxide Dismutase Mutants That Cause Amyotrophic Lateral Sclerosis
J. Biol. Chem.,
May 6, 2005;
280(18):
17725 - 17731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fukada, F. Zhang, A. Vien, N. R. Cashman, and H. Zhu
Mitochondrial Proteomic Analysis of a Cell Line Model of Familial Amyotrophic Lateral Sclerosis
Mol. Cell. Proteomics,
December 1, 2004;
3(12):
1211 - 1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|